Differences in Overall Survival for Non-Western Immigrant Patients Compared to DanishBorn Patients with Diffuse Large B-Cell Lymphoma
Simonsen, MR, Jakobsen, LH, Severinsen, MT, Frederiksen, H, Utoft, C, Niemann, CU, Joergensen, JM, Clausen, MR, Starklint, J, Johnsen, SP, El-Galaly, TC, Baech, J
Published in BLOOD (2023)
Published in BLOOD (2023)
Get full text
Conference Proceeding
Subcutaneous epcoritamab plus GemOx in patients with relapsed or refractory DLBCL: Updated results from EPCORE NHL-2
Brody, JD, Joergensen, JM, Belada, D, Costello, R, Trneny, M, Vitolo, U, Lewis, DJ, Karimi, Y, Sureda, A, Andre, M, Wahlin, BE, Lugtenburg, P, Jiang, YJ, Abbas, A, Song, YO, Risum, M, Cordoba, R
Published in JOURNAL OF CLINICAL ONCOLOGY (2024)
Get full text
Published in JOURNAL OF CLINICAL ONCOLOGY (2024)
Conference Proceeding
Epcoritamab SC plus GemOx Leads to High Complete Metabolic Response Rates in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Ineligible for Autologous Stem Cell Transplant: Updated Results from Epcore NHL-2
Brody, J, Joergensen, JM, Belada, D, Costello, RT, Trneny, M, Vitolo, U, Lewis, D, Karimi, YH, Balari, AMS, Andre, M, Wahlin, BE, Lugtenburg, P, Galderisi, F, Abbas, A, Song, YO, Risum, M, Cordoba, R
Published in BLOOD (2023)
Published in BLOOD (2023)
Get full text
Conference Proceeding